Reazioni tandem organocatalitiche enantioselettive di derivati indolici e nitroetene: un accesso diretto a precursori di alcaloidi dell'Ergot

Il lavoro discusso in questa tesi è lo sviluppo di un metodo sintetico basato sulla catalisi asimmetrica che consente di ottenere precursori di alcuni alcaloidi dell’Ergot in forma enantioarricchita. La reazione sviluppata consiste in un processo domino Friedel-Crafts/nitro-Michael fra indoli sostituiti in posizione 4 con un accettore di Michael e nitroetene. I catalizzatori utilizzati sono in grado di attivare il nitroetene per la Friedel-Crafts mediante legami a idrogeno e di indurre stereoselezione nella successiva ciclizzazione di Michael intramolecolare. Mediante la procedura ottimizzata è possibile ottenere una serie di indoli policiclici, potenziali precursori sintetici di alcaloidi dell’Ergot, con buone rese ed enantioselezioni.

Beyond simple proton transfer processes: domino reactions between 4-substituted indoles and nitroethene as a new gateway to ergot alkaloids

The multimodal biology activity of ergot alkaloids is known by humankind since middle ages. Synthetically modified ergot alkaloids are used for the treatment of various medical conditions. Despite the great progress in organic syntheses, the total synthesis of ergot alkaloids remains a great challenge due to the complexity of their polycyclic structure with multiple stereogenic centres. This project has developed a new domino reaction between indoles bearing a Michael acceptor at the 4 position and nitroethene, leading to potential ergot alkaloid precursors in highly enantioenriched form. The reaction was optimised and applied to a large variety of substrate with good results. Even if unfortunately all attempts to further modify the obtained polycyclic structure failed, it was found a reaction able to produce the diastereoisomer of the polycyclic product in excellent yields. The compounds synthetized were characterized by NMR and ESIMS analysis confirming the structure and their enantiomeric excess was determined by chiral stationary phase HPLC. The mechanism of the reaction was evaluated by DFT calculations, showing the formation of a key bicoordinated nitronate intermediate, and fully accounting for the results observed with all substrates. The relative and absolute configuration of the adducts were determined by a combination of NMR, ECD and computational methods.

Mémoire historique sur l'emploi du seigle ergoté pour accélérer ou déterminer l'accouchement ou la délivrance dans le cas d'inertie de la matrice /

Mode of access: Internet.

Mémoire sur l'ergot de seigle, son action thérapeutique et son emploi médical /

Mode of access: Internet.

Traité sur l'emploi thérapeutique du seigle ergoté /

Mode of access: Internet.

On the ergot of rye.

Linn.soc.London.Trans.18:475-482. pl.32-33. 1841.

Ergot of rye - the first specific for migraine

Over the past decade the various triptan derivatives have been accepted as the most effective available agents for relieving migraine attacks. Prior to that, for a period of half a century, ergotamine was the only 'specific' available for this purpose. In 1918, Stoll had isolated it from the various alkaloids present in extracts of the sclerotia of the fungus Claviceps purpurea (ergot), which grow on rye and, to a lesser extent, on other grasses. By 1925 ergotamine was beginning to be used to treat migraine attacks. However, as ergotamine was present in extracts of ergot, which had been used to treat migraine first, In Italy in 1862, and then by Edward Woakes (11868) in England, and after him by Albert Eulenburg in Germany (1883), the drug had actually come into unrecognised use for the disorder more than half a century before ergotamine itself was known to exist. Unfortunately, because of ergotamine's chemical and pharmacokinetic properties, extracts of ergot of rye were incapable of producing consistent therapeutic results, so that general acceptance that the first specific substance for migraine treatment existed had to wait until pure ergotamine was available for administration. (C) 2003 Elsevier Ltd. All rights reserved.